X-ray repair cross-complementing protein 1 (XRCC1) loss promotes β-lapachone –induced apoptosis in pancreatic cancer cells
Abstract Background β-lapachone (β-lap), the NQO1 bioactivatable drug, is thought to be a promising anticancer agent. However, the toxic side effects of β-lap limit the drug use, highlighting the need for a thorough understanding of β-lap’s mechanism of action. β-lap undergoes NQO1-dependent futile...
Main Authors: | Yansong Zheng, Hengce Zhang, Yueting Guo, Yuan Chen, Hanglong Chen, Yingchun Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-11-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12885-021-08979-y |
Similar Items
-
Association of XRCC1, XRCC2 and XRCC3 Gene Polymorphism with Esophageal Cancer Risk
by: Kaur J, et al.
Published: (2020-03-01) -
Association Studies Between XRCC1, XRCC2, XRCC3 Polymorphisms and Differentiated Thyroid Carcinoma
by: Li Yan, et al.
Published: (2016-03-01) -
Polymorphisms of the DNA repair genes XRCC1 and XRCC3 in a Brazilian population
by: Márcia Cristina Duarte, et al.
Published: (2005-09-01) -
POLIMORPHISM OF XRCC1, XRCC2, XRCC3 GENES IN LUNG CANCER PATIENTS AND HEALTHY PEOPLE OF KEMEROVO REGION
by: A. V. Ryzhkova, et al.
Published: (2014-09-01) -
DNA Repair Genes and Chronic Myeloid Leukemia: XPD (751), XRCC1 (399), XRCC4-Intron 3, XRCC4 (1394) Gene Polymorphisms
by: Istemi SERIN, et al.
Published: (2021-02-01)